119 related articles for article (PubMed ID: 10211938)
1. Rapid development of glutathione-S-transferase-dependent drug resistance in vitro and its prevention by ethacrynic acid.
Caffrey PB; Zhu M; Zhang Y; Chinen N; Frenkel GD
Cancer Lett; 1999 Feb; 136(1):47-52. PubMed ID: 10211938
[TBL] [Abstract][Full Text] [Related]
2. Prevention of the development of melphalan resistance in vitro by selenite.
Caffrey PB; Zhu M; Frenkel GD
Biol Trace Elem Res; 1998 Dec; 65(3):187-95. PubMed ID: 9892492
[TBL] [Abstract][Full Text] [Related]
3. Sensitization to the cytotoxicity of melphalan by ethacrynic acid and hyperthermia in drug-sensitive and multidrug-resistant Chinese hamster ovary cells.
Turcotte S; Averill-Bates DA
Radiat Res; 2001 Sep; 156(3):272-82. PubMed ID: 11500136
[TBL] [Abstract][Full Text] [Related]
4. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
Caffrey PB; Zhang Y; Frenkel GD
Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid.
Hansson J; Berhane K; Castro VM; Jungnelius U; Mannervik B; Ringborg U
Cancer Res; 1991 Jan; 51(1):94-8. PubMed ID: 1988111
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu.
Horton JK; Roy G; Piper JT; Van Houten B; Awasthi YC; Mitra S; Alaoui-Jamali MA; Boldogh I; Singhal SS
Biochem Pharmacol; 1999 Aug; 58(4):693-702. PubMed ID: 10413308
[TBL] [Abstract][Full Text] [Related]
7. A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.
Rhodes T; Twentyman PR
Br J Cancer; 1992 May; 65(5):684-90. PubMed ID: 1316774
[TBL] [Abstract][Full Text] [Related]
8. Treatment of human ovarian tumor xenografts with selenite prevents the melphalan-induced development of drug resistance.
Caffrey PB; Frenkel GD
Anticancer Res; 1998; 18(4C):3017-20. PubMed ID: 9713502
[TBL] [Abstract][Full Text] [Related]
9. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
10. Modulation of melphalan and cisplatin cytotoxicity in human ovarian cancer cells resistant to alkylating drugs.
Gornati D; Zaffaroni N; Villa R; De Marco C; Silvestrini R
Anticancer Drugs; 1997 Jun; 8(5):509-16. PubMed ID: 9215615
[TBL] [Abstract][Full Text] [Related]
11. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
Pu Q; Bianchi P; Bezwoda WR
Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
[TBL] [Abstract][Full Text] [Related]
12. Modulation of melphalan cytotoxic activity in human melanoma cell lines.
Supino R; Caserini C; Orlandi L; Zaffaroni N; Silvestrini R; Vaglini M; Zunino F
Anticancer Drugs; 1996 Jul; 7(5):604-12. PubMed ID: 8862730
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell heterogeneity: impact on mechanisms of therapeutic drug resistance.
Richardson ME; Siemann DW
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):789-95. PubMed ID: 9369124
[TBL] [Abstract][Full Text] [Related]
14. Short divalent ethacrynic amides as pro-inhibitors of glutathione
Xu B; Tong T; Wang X; Liu F; Zhang X; Hu X; Li X; Yang X; Liao F
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):728-742. PubMed ID: 35176963
[TBL] [Abstract][Full Text] [Related]
15. Chemical modulation of chemotherapy resistance in cultured oesophageal carcinoma cells.
Sheehan D; Meade G
Biochem Soc Trans; 2000 Feb; 28(2):27-32. PubMed ID: 10816094
[TBL] [Abstract][Full Text] [Related]
16. Varying the metal to ethacrynic acid ratio in ruthenium(ii)/osmium(ii)-p-cymene conjugates.
Păunescu E; Soudani M; Clavel CM; Dyson PJ
J Inorg Biochem; 2017 Oct; 175():198-207. PubMed ID: 28779652
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
Létourneau S; Palerme JS; Delisle JS; Beauséjour CM; Momparler RL; Cournoyer D
Cancer Gene Ther; 2000 May; 7(5):757-65. PubMed ID: 10830723
[TBL] [Abstract][Full Text] [Related]
18. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
Chen G; Waxman DJ
Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907
[TBL] [Abstract][Full Text] [Related]
19. In vitro reversal of glutathione-S-transferase-mediated resistance in canine osteosarcoma (COS31) cells.
Shoieb AM; Hahn KA; Van Laack RL; Barnhill MA
In Vivo; 1998; 12(5):455-62. PubMed ID: 9827351
[TBL] [Abstract][Full Text] [Related]
20. Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines.
Strumberg D; Harstrick A; Doll K; Hoffmann B; Seeber S
Anticancer Drugs; 1996 Jun; 7(4):415-21. PubMed ID: 8826610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
